[HTML][HTML] HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial
G Aasbø, A Tropè, M Nygård, IK Christiansen… - British Journal of …, 2022 - nature.com
Background Cervical cancer screening participation is suboptimal in most settings. We
assessed whether human papillomavirus (HPV) self-sampling may increase screening …
assessed whether human papillomavirus (HPV) self-sampling may increase screening …
HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: A pragmatic randomized controlled trial
G Aasbø, A Tropè, M Nygård, IK Christiansen… - medRxiv, 2022 - medrxiv.org
Background The main aim of the present study is to assess whether human papillomavirus
(HPV) self-sampling may increase cervical cancer screening participation among long-term …
(HPV) self-sampling may increase cervical cancer screening participation among long-term …
HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial.
G Aasbø, A Tropè, M Nygård, IK Christiansen… - British Journal of …, 2022 - europepmc.org
Background Cervical cancer screening participation is suboptimal in most settings. We
assessed whether human papillomavirus (HPV) self-sampling may increase screening …
assessed whether human papillomavirus (HPV) self-sampling may increase screening …
HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial
G Aasbø, A Trope, M Nygård, IK Christiansen… - 2022 - bora.uib.no
Background Cervical cancer screening participation is suboptimal in most settings. We
assessed whether human papillomavirus (HPV) self-sampling may increase screening …
assessed whether human papillomavirus (HPV) self-sampling may increase screening …
[HTML][HTML] HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial
G Aasbø, A Tropè, M Nygård… - British Journal of …, 2022 - ncbi.nlm.nih.gov
Background Cervical cancer screening participation is suboptimal in most settings. We
assessed whether human papillomavirus (HPV) self-sampling may increase screening …
assessed whether human papillomavirus (HPV) self-sampling may increase screening …
HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial
G Aasbø, A Trope, M Nygård, IK Christiansen… - 2022 - fhi.brage.unit.no
Background Cervical cancer screening participation is suboptimal in most settings. We
assessed whether human papillomavirus (HPV) self-sampling may increase screening …
assessed whether human papillomavirus (HPV) self-sampling may increase screening …
HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial
G Aasbø, A Trope, M Nygård, IK Christiansen… - 2022 - ntnuopen.ntnu.no
Background Cervical cancer screening participation is suboptimal in most settings. We
assessed whether human papillomavirus (HPV) self-sampling may increase screening …
assessed whether human papillomavirus (HPV) self-sampling may increase screening …
HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial
G Aasbø, A Trope, M Nygård, IK Christiansen… - 2022 - stami.brage.unit.no
Background Cervical cancer screening participation is suboptimal in most settings. We
assessed whether human papillomavirus (HPV) self-sampling may increase screening …
assessed whether human papillomavirus (HPV) self-sampling may increase screening …
HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial
G Aasbø, A Tropè, M Nygård, IK Christiansen… - 2022 - pubmed.ncbi.nlm.nih.gov
Background Cervical cancer screening participation is suboptimal in most settings. We
assessed whether human papillomavirus (HPV) self-sampling may increase screening …
assessed whether human papillomavirus (HPV) self-sampling may increase screening …
HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial
G Aasbø, A Trope, M Nygård, IK Christiansen… - British Journal of …, 2022 - duo.uio.no
Background Cervical cancer screening participation is suboptimal in most settings. We
assessed whether human papillomavirus (HPV) self-sampling may increase screening …
assessed whether human papillomavirus (HPV) self-sampling may increase screening …